BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10925618)

  • 1. [Migraine patients and oral contraceptives].
    Salvesen R
    Tidsskr Nor Laegeforen; 2000 Jun; 120(16):1883-4. PubMed ID: 10925618
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined hormonal contraceptives and migraine: An update on the evidence.
    Calhoun AH; Batur P
    Cleve Clin J Med; 2017 Aug; 84(8):631-638. PubMed ID: 28806162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives in migraine.
    Allais G; Gabellari IC; De Lorenzo C; Mana O; Benedetto C
    Expert Rev Neurother; 2009 Mar; 9(3):381-93. PubMed ID: 19271947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined hormonal contraceptives: is it time to reassess their role in migraine?
    Calhoun A
    Headache; 2012 Apr; 52(4):648-60. PubMed ID: 22221001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Migraine and risk of cerebral infarction].
    Tzourio C; Bousser MG
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S47-56. PubMed ID: 11139748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive use and risk of stroke.
    Xuereb M; Pullicino P
    Stroke; 1988 Jul; 19(7):922-3. PubMed ID: 3388464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Migraine patients and oral contraceptives].
    Engstrøm M
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2579. PubMed ID: 11071001
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
    Urdinola J
    Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC).
    Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Sandset PM; Martelletti P;
    J Headache Pain; 2017 Oct; 18(1):108. PubMed ID: 29086160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
    Loder EW; Buse DC; Golub JR
    Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxytetral and Lindynette].
    Ravnbak K
    Ugeskr Laeger; 2006 Sep; 168(39):3335; author reply 3335. PubMed ID: 17036420
    [No Abstract]   [Full Text] [Related]  

  • 14. An evidence-based approach to hormonal contraception and headaches.
    Harris M; Kaneshiro B
    Contraception; 2009 Nov; 80(5):417-21. PubMed ID: 19835714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal contraceptive patch].
    Lidegaard O
    Ugeskr Laeger; 2004 Oct; 166(41):3591. PubMed ID: 15515462
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexisting typical migraine in familial hemiplegic migraine.
    Hansen JM; Thomsen LL; Olesen J; Ashina M
    Neurology; 2010 Feb; 74(7):594-600. PubMed ID: 20157162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of oral contraceptives in patients with migraine.
    Becker WJ
    Neurology; 1999; 53(4 Suppl 1):S19-25. PubMed ID: 10487509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors and migraine: the GEM population-based study.
    Scher AI; Terwindt GM; Picavet HS; Verschuren WM; Ferrari MD; Launer LJ
    Neurology; 2005 Feb; 64(4):614-20. PubMed ID: 15728281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein may be increased in migraine patients who present with complex clinical features.
    Welch KM; Brandes AW; Salerno L; Brandes JL
    Headache; 2006 Feb; 46(2):197-9. PubMed ID: 16492227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.